WHO Ministerial Conference Provided Opportunity For Global TB Community To Accelerate Progress Against Disease

The Lancet Global Health: Tuberculosis makes it onto the international political agenda for health … finally
Mario Raviglione, director of the Global TB Programme at the WHO, and colleagues

“…The latest global burden of disease assessment measuring progress on health-related [Sustainable Development Goals (SDGs)] concludes that tuberculosis is one of the health challenges for which dramatic acceleration of progress is most needed. … Within the health-related SDG3 targets, universal health coverage and controlling the epidemics of HIV, diabetes, alcohol-use disorders, and tobacco smoking need to be addressed. The drivers and determinants of the tuberculosis epidemic and the direct risk factors for tuberculosis will, however, need action on other, non-health-related SDGs. These include addressing poverty and social protection (SDG1), hunger (SDG2), indoor air pollution (SDG7), working and living conditions (SDG8), inequalities (SDG10), and urban slums (SDG11). … The WHO Ministerial Conference in November, 2017, should provide ministers of health and their heads of state with essential building blocks towards achieving revolutionary commitments in 2018, and beyond” (11/15).

Thomson Reuters Foundation: To protect against antimicrobial resistance, focus on saving lives from tuberculosis
Jaak Peeters, head of global public health at Johnson & Johnson

“…We have an opportunity to accelerate progress … when the global community meets in Moscow to focus on tuberculosis (TB) … If we can take a holistic approach in turning the tide on TB, we can begin to turn the tide on antimicrobial resistance [AMR] overall. … We desperately need a new operating model, based on shared goals, responsibility, and accountability, to solve the burden of [drug-resistant TB (DR-TB)] and the broader AMR challenge. It will take a sustainable ecosystem built around appropriate financing, incentives, stewardship, and in-country transparency and performance management to support the rapid acceleration of progress against DR-TB and AMR. … I’m convinced that if we all band together and do our part to stop TB, we can do the same to protect the world’s supply of life-saving antibiotics” (11/17).